logo
Products
Services
Resources
Selection Guides
About
mFluor™ Violet 510 Anti-human CD25 Antibody
7G7B6
The 7G7B6 monoclonal antibody recognizes human CD25, a 55 kD glycoprotein often located on the surface of oligodendrocytes, T cells, B cells and thymocytes. In certain organisms, CD25 negatively regulates defense response to virus, downregulates inflammatory response and positively regulates activated T cell proliferation. Additionally, it is involved with critical cellular pathways, for instance, the interleukin-2-mediated signaling pathway, cell surface receptor signaling pathway and cytokine-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands like IL-2. CD25 is a very popular antibody target, with over 40000 publications in the last decade. CD25 is vital to immunology research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to mFluor™ Violet 510 (ex/em = 412/505 nm). It is compatible with the 405 nm laser and 525/50 nm bandpass filter (for example, as in the Miltenyi Biotec MACSQuant Analyzer 10).
product image
CatalogSize
Price
Quantity
10251110100 tests
Price
10251111500 tests
Price
 
Antibody properties

Other namesIL-2Rα, p55, TAC antigen
Clone7G7B6
HostMouse
IsotypeIgG2a
ReactivityHuman
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Absorbance (nm)410
Correction factor (260 nm)0.464
Correction factor (280 nm)0.366
Extinction coefficient (cm -1 M -1)
25000
1
Excitation (nm)412
Emission (nm)505
Quantum yield
0.86
1
Usage and storage

Intended useResearch Use Only (RUO)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 21, 2026